🔬 Breakthrough Advancement in Clinical Research for the Treatment of Keratoconus 🔬 We are excited to announce the publication of the ARGO clinical trial validating theranostics technology for the precision, predictive and personalized treatment of ke ...
Regensight at ESCRS 2024
Regensight will join the most important and awaited International Annual Conference in corneal and cataract surgery organized by ESCRS in Barcelona (https://congress.escrs.org/) on 6-10 September 2024. With validation of theranostics in the randomized mu ...
New Publication on Regensight: A Clear Future for Young People with Keratoconus
We are excited to announce the publication of a new scientific article, entitled "Spatial targeted delivery of riboflavin with a controlled corneal iontophoresis delivery system in theranostic-guided UV-A light photo-therapy", in the prestigious Journal ...
Pre-clinical validation outcomes of theranostic-guided corneal cross-linking published
In a recent study published in the prestigious Journal of Cataract & Refractive Surgery, theranostic-guided corneal cross-linking has been confirmed to induce precise and predictive corneal tissue strengthening in eye-bank human donor tissues through ...